Project Grant HT94252310654
Award Date
7/1/23
Completion Date
7/30/27
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Milwaukee, WI 53226, USA
Similar Awards
The Medical College of Wisconsin, Inc. was awarded a $935,999 Project Grant from the Defense Health Agency on April 15, 2023 to complete work by April 14, 2027. The grant is part of the agency's Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions for battlefield medicine and other priorities. Specifically, this award will fund research into...
The Medical College of Wisconsin, Inc. was awarded a $927,600 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 2021 to May 2025 to target epigenomic adaptations to overcome drug resistance in ovarian cancer. Through this funding, the awardee will investigate medical solutions for ovarian cancer treatment and deliver innovative biomedical research with the...
This Project Grant award of $487,217.00 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research to evaluate the safety of cervical arthroplasty for Navy and Marine Corps tactical jet aircrew. The award was made to The Medical College of Wisconsin, Inc., a private non-profit medical school and research institution, on September 30, 2024 with a final completion date of September 29, 2027. The funded research aims...
The Defense Health Agency has awarded a $862,751 Project Grant to the University of Wisconsin-Milwaukee (UWM) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective June 1, 2024 through May 31, 2027, will fund a research project to study the "Impact of Recent Childbirth on Breast Cancer Prognosis and Tumor Molecular Phenotypes Among Young Black and White Women." This grant supports UWM's ongoing biomedical research initiatives focused on...
The Medical College of Wisconsin, Inc. was awarded a $431,763 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2025 to investigate how the bacterium Borrelia burgdorferi alters host immune responses and induces autoimmunity. Through this research, the awardee aims to advance understanding of medical solutions for battlefield wounds as described in...
The Defense Health Agency awarded a 3-year, $2,289,304 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Medical College of Wisconsin, Inc. to improve in-hospital and post-discharge patient education for mild traumatic brain injury. The project aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis, treatment, and management of conditions relevant to...
This federal Project Grant award, valued at $1,555,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the University of Wisconsin System's research initiative to develop population modeling to optimize equitable ovarian cancer outcomes. The project aims to transform healthcare for military service members and the broader public by advancing innovative research on disease prevention, diagnosis, and...
This $1,146,270 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System to target a lipid kinase regulator of nuclear Akt in breast cancer. The project aims to transform health care for Service Members and the American public through innovative and impactful research, with a focus on medical solutions for the battlefield. The grant will fund research activities at the University of...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $155,500.00 to the University of Wisconsin System to develop a model for studying tumor-normal cell interaction in vitro for high-throughput drug screening. The award period runs from December 1, 2024 to November 30, 2025. The project aims to advance medical research and treatment of conditions relevant to military personnel and the broader...
The University of Wisconsin System was awarded a $995,076 project grant by the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the development of new agents for the treatment of hormone receptor positive and HER2 positive breast cancer. The grant was awarded on Dec 15, 2023 and is scheduled for completion on Dec 14, 2026. As part of this project, the University of Wisconsin System has sub-awarded funding to Loyola University of...